Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In an attempt to examine chronic effects of toluene on sleep, spontaneous locomotor activity and drinking behavior, rats were repeatedly administered toluene i.p. at doses of 100 and 200 mg/kg body weight for 14 consecutive days. The 200-mg/kg injections induced a decrease in total sleep on Day 1, an increase in locomotor activity on Days 1 through 4 and an increase in drinking activity on Days 0 through 6 after discontinuation of the daily injections. Both the reduced sleep and the increased locomotor activity appeared during the light period, whereas the drinking activity increased during the dark period. In order to find neurochemical correlates of the toluene-induced changes in behavior, regional concentrations of brain monoamines and their metabolites were determined. The toluene-induced partial
insomnia
and hyperactivity were associated with lowered concentrations of serotonin in frontal cortex, hippocampus and midbrain and 5-hydroxyindoleacetic acid in midbrain and hypothalamus. The increased drinking activity was associated with increased concentrations of striatal 3,4-dihydroxy-
phenylacetic acid
and homovanillic acid and hypothalamic noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol. Central monoaminergic mechanisms were implicated in the toluene-induced partial
insomnia
, hyperactivity and hyperdipsia.
...
PMID:Partial insomnia, hyperactivity and hyperdipsia induced by repeated administration of toluene in rats: their relation to brain monoamine metabolism. 406 Jan 73